1World Health Organization. Hepatitis. B. World Health Or-ganization Fact Sheet 204 dex. ( Revised October 2000) WHO Web site [ EB/OL]. http : //www. who. int/mediacen-tre/fact sheets/fs204/en/in btml.
3Beckebaum S, Gicinnati VR, Zhang X. Hepatitis B virus-induced defect of monocytes-derived dendritic cells lead to impaired T helper type I response in vitro: mechanisms for viral immune eseape [J]. Immunology, 2003, 109: 487-95.
4Hashimoto Y, Suzuki F, Hirakawa M. Clinical and virological effects of long-term (over 5 years) lamivudine therapy[J]. J Meal Virol, 2010, 82(4): 684-91.
5骆抗先.乙型肝炎基础和临床[M].2版.北京:人民卫生出版社,2001.56-73.
6田庚善.病毒性肝炎及肝病诊疗手册[M].北京:中国科学技术出版社,2003:100-101.
7Yuen MF, Lai CL. Treatment of chronic hepatitis B: evolution over two decades [J ]. J Gastroenterol Hepatol, 2011, 26(Suppl 1):S 138- S143.
